The timeline of their press releases is interesting, to say the least:
03-03-2020
CureVac CEO Daniel Menichella Discusses Coronavirus Vaccine Development with U.S. President Donald Trump and Members of Coronavirus Task Force
03-11-2020
Company Founder Ingmar Hoerr Succeeds Daniel Menichella as CEO of CureVac AG
03-15-2020
CureVac focuses on the development of mRNA-based coronavirus vaccine to protect people worldwide